Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd Infertility Center: A cross-sectional study

Abstract Background Hyperprolactinemia is one of the most common causes of infertility in women. The prevalence of pituitary tumors is 25-30% among infertile participants with hyperprolactinemia. Objective The aim of this study was to describe the causes of hyperprolactinemia in infertile women referred to Yazd Infertility Center. Materials and Methods This cross-sectional study was conducted with 182 infertile women with hyperprolactinemia who were referred to Yazd Infertility Center from February 2018 to October 2019. Serum prolactin was assessed by the human prolactin ELISA kit according to the Padtan Gostar Isar protocol. The age, duration of infertility, causes of hyperprolactinemia, and type of infertility treatment were noted. The MRI findings were added. Results The mean age of participants was 28.9 ± 0.36 yr and the prolactin level was 76 ± 8.97 ng/ml. The etiology of hyperprolactinemia among the study participants was 35 participants (19.2%) with pituitary adenoma, 47 participants (25.8%) with polycystic ovary syndrome, 14 participants (7.7%) with pituitary adenoma and polycystic ovary syndrome, and 86 participants (47.3%) with idiopathic hyperprolactinemia. The results of this study showed that there was no statistically significant difference between the mean prolactin levels in participants with different causes of hyperprolactinemia (p = 0.31). Conclusion Idiopathic hyperprolactinemia and polycystic ovary syndrome are the most common reasons for hyperprolactinemia.

[1]  W. Hussein,et al.  Hyperprolactinemia and polycystic ovary syndrome: The debate continues , 2020, Ibnosina Journal of Medicine and Biomedical Sciences.

[2]  Arun Koyyada,et al.  Role of hypothyroidism and associated pathways in pregnancy and infertility: Clinical insights , 2020, Tzu chi medical journal.

[3]  Jacques Young,et al.  PCOS and Hyperprolactinemia: what do we know in 2019? , 2019, Clinical medicine insights. Reproductive health.

[4]  M. Ganie,et al.  Idiopathic Hyperprolactinemia Presenting as Polycystic Ovary Syndrome in Identical Twin Sisters: A Case Report and Literature Review , 2018, Cureus.

[5]  H. Randeva,et al.  The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome , 2018, European journal of clinical investigation.

[6]  I. Aliyu,et al.  Hyperprolactinemia and female infertility: Pattern of clinical presentation in a tertiary health facility in Northern Nigeria , 2018 .

[7]  K. Serin,et al.  Pituitary Adenoma and Hyperprolactinemia Accompanied by Idiopathic Granulomatous Mastitis , 2017, Case reports in endocrinology.

[8]  G. Leese,et al.  The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS) , 2017, Clinical endocrinology.

[9]  F. Altıntoprak,et al.  Aetiology of idiopathic granulomatous mastitis. , 2014, World journal of clinical cases.

[10]  P. Klenerman,et al.  Mutant prolactin receptor and familial hyperprolactinemia. , 2013, The New England journal of medicine.

[11]  Amy T. Wang,et al.  Treatment of hyperprolactinemia: a systematic review and meta-analysis , 2012, Systematic Reviews.

[12]  P. Crosignani Management of hyperprolactinemic infertility , 2012 .

[13]  T. Toth,et al.  Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility. , 2010, Fertility and sterility.

[14]  A. Saxena,et al.  Correlation of Prolactin and Thyroid Hormone Concentration with Menstrual Patterns in Infertile Women , 2009, Journal of reproduction & infertility.

[15]  A. Falorni,et al.  Pharmacological causes of hyperprolactinemia , 2007, Therapeutics and clinical risk management.

[16]  P. Touraine,et al.  Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. , 2007, Annales d'endocrinologie.

[17]  L. Naves,et al.  Polycystic ovary syndrome and hyperprolactinemia are distinct entities , 2007, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[18]  R. Paulson,et al.  Pituitary imaging is indicated for the evaluation of hyperprolactinemia. , 2005, Fertility and sterility.

[19]  A. Tuzcu,et al.  Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome? , 2003, Journal of endocrinological investigation.

[20]  A. Tuzcu,et al.  Insulin sensitivity and hyperprolactinemia , 2003, Journal of endocrinological investigation.

[21]  N. Hattori Macroprolactinemia: a new cause of hyperprolactinemia. , 2003, Journal of Pharmacological Sciences.

[22]  R. Baveja,et al.  PROLACTIN LEVEL IN INFERTILITY WITH MENSTRUAL IRREGULARITIES , 2002 .

[23]  U. Zollner,et al.  Assessment of endocrine status in patients undergoing in-vitro fertilization treatment , 2001, Archives of Gynecology and Obstetrics.

[24]  S. Melmed,et al.  Pituitary tumor registry: a novel clinical resource. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  R. Croughs,et al.  [Hyperprolactinemia and prolactinomas]. , 1991, Nederlands tijdschrift voor geneeskunde.